We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
89 hedge funds and large institutions have $80.7M invested in Zevra Therapeutics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 37 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
59% more call options, than puts
Call options by funds: $707K | Put options by funds: $446K
6% more funds holding
Funds holding: 84 → 89 (+5)
2.85% more ownership
Funds ownership: 31.43% → 34.29% (+2.9%)
3% less capital invested
Capital invested by funds: $83.5M → $80.7M (-$2.85M)
43% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 37
Holders
89
Holders Change
+5
Holders Change %
+5.95%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
21
Reduced
37
Closed
7
Calls
$707K
Puts
$446K
Net Calls
+$261K
Net Calls Change
+$1.18M
Top Buyers
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.06M |
| 2 |
AC
Armistice Capital
New York
|
-$1.76M |
| 3 |
Morgan Stanley
New York
|
-$358K |
| 4 |
VF
Virtu Financial
New York
|
-$177K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$161K |
